MBCL-03. RESULTS OF HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Medulloblastoma is a highly lethal disease when it recurs. Very few patients survive with second line conventional treatment after relapse. This study evaluated the use of high-dose thiotepa, carboplatin and etoposide with autologous hematopoietic stem-cell transplantation (HSCT) in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gevorgian, Asmik, Tolkunova, Polina, Kazantsev, Ilya, Iukhta, Tatiana, Kozlov, Andrew, Zvyagintseva, Darya, Morozova, Elena, Zubarovskaya, Ludmila, Afanasiev, Boris, Zheludkova, Olga, Punanov, Yury
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715147/
http://dx.doi.org/10.1093/neuonc/noaa222.479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715147/
http://dx.doi.org/10.1093/neuonc/noaa222.479

Ejemplares similares